Innovative Interventions for Smoking Cessation
Innovative Interventions for Smoking Cessation: Comparison of Very Low Nicotine Content Cigarettes Plus Nicotine Patch; Very Low Nicotine Content Cigarettes Alone or Nicotine Patch Alone
研究概览
详细说明
The purpose of this study is to evaluate the effect of a combination of the 21 mg nicotine patch and very low nicotine content cigarette (VLNC) compared to the VLNC cigarette alone or 21 mg nicotine patch alone on abstinence, time to relapse and toxicant levels.
The following primary hypothesis will be tested:
Abstinence rates will be highest and the time to relapse will be the longest in the VLNC cigarettes plus nicotine patch condition compared to nicotine patch or VLNC cigarettes alone.
Other hypotheses include:
- Greater positive subjective responses to cigarettes will be observed with VLNC cigarettes plus patch vs. VLNC cigarette;
- Less drop-outs will be observed in the VLNC plus patch vs the other two conditions; and
- Less compensatory smoking will be observed in the VLNC plus patch condition compared to VLNC cigarette alone condition.
Cigarette smokers will be randomized to:
- VLNC cigarettes (which provide sensory behavioral aspects of smoking but with limited nicotine) plus nicotine patch for 6 weeks;
- Nicotine patch for 6 weeks; or
- VLNC cigarettes alone.
Outcome measures will include cessation assessed at the end of treatment as the primary endpoint and at 36 weeks post-treatment, time to lapse and relapse to usual brand cigarettes, and biomarkers of toxicant exposure. Predictors of abstinence and treatment response for each of the treatment conditions will be explored.
研究类型
注册 (实际的)
阶段
- 阶段2
联系人和位置
学习地点
-
-
Minnesota
-
Duluth、Minnesota、美国、55812
- University of Minnesota
-
Minneapolis、Minnesota、美国、55414
- University of MN's Tobacco Use Research Center
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- a) Smoking at least 10 cigarettes daily for the past year;
- b) In good physical health;
- c) No contraindications for medicinal nicotine; and
- d) Stable, good mental health.
Exclusion Criteria:
- a) Subjects must not be using other tobacco or nicotine products.
- b) Female subjects cannot be pregnant or nursing and must be using appropriate birth control.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:阶乘赋值
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:VLNC Cigarette
Very Low Nicotine Content Cigarette.
Dosage: 0.05 mg to 0.09 mg nicotine yield cigarette; Frequency: Daily; Duration: 6 weeks.
|
Cigarette where the tobacco contains <0.1 mg of nicotine yield.
其他名称:
|
|
有源比较器:Nicotine Patch
21 mg nicotine patch.
Dosage: 21 mg; Frequency: Daily; Duration: 6 weeks.
|
21 mg
其他名称:
|
|
实验性的:VLNC Cigarette plus Nicotine Patch
Very Low Nicotine Content Cigarette plus 21 mg Nicotine Patch.
Patch Dosage: 21 mg; Cigarette Dosasge: 0.05 to 0.09 mg nicotine yield; Frequency: Daily; Duration: 6 weeks
|
21 mg nicotine patch plus use of cigarette with tobacco containing <0.1 mg nicotine yield.
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
End of Treatment Abstinence Rate
大体时间:12 week
|
Cotinine and carbon monoxide (CO) verified point prevalence abstinence
|
12 week
|
|
End of Follow-up Abstinence Rates
大体时间:36 weeks
|
CO- and cotinine-verified point prevalence abstinence
|
36 weeks
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Exposure to Tobacco Toxicants
大体时间:6 weeks
|
6 weeks
|
|
Time to Lapse or Relapse to Tobacco Use
大体时间:26 weeks
|
26 weeks
|
合作者和调查者
出版物和有用的链接
一般刊物
- Dermody SS, Donny EC, Hertsgaard LA, Hatsukami DK. Greater reductions in nicotine exposure while smoking very low nicotine content cigarettes predict smoking cessation. Tob Control. 2015 Nov;24(6):536-9. doi: 10.1136/tobaccocontrol-2014-051797. Epub 2014 Sep 5.
- Hatsukami DK, Hertsgaard LA, Vogel RI, Jensen JA, Murphy SE, Hecht SS, Carmella SG, al'Absi M, Joseph AM, Allen SS. Reduced nicotine content cigarettes and nicotine patch. Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1015-24. doi: 10.1158/1055-9965.EPI-12-1439. Epub 2013 Apr 19.
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.